| Literature DB >> 24772018 |
Rayees Ahmad Shiekh1, Maqsood Ahmad Malik2, Shaeel Ahmed Al-Thabaiti2, Mohmmad Younus Wani3, Arshid Nabi4.
Abstract
2-Phenyl-N,N'-bis(pyridin-4-ylcarbonyl)butanediamide ligand with a series of transition metal complexes has been synthesized via two routes: microwave irradiation and conventional heating method. Microwave irritation method happened to be the efficient and versatile route for the synthesis of these metal complexes. These complexes were found to have the general composition M(L)Cl2/M(L)(CH3COO)2 (where M = Cu(II), Co(II), Ni(II), and L = ligand). Different physical and spectroscopic techniques were used to investigate the structural features of the synthesized compounds, which supported an octahedral geometry for these complexes. In vitro antifungal activity of the ligand and its metal complexes revealed that the metal complexes are highly active compared to the standard drug. Metal complexes showed enhanced activity compared to the ligand, which is an important step towards the designing of antifungal drug candidates.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24772018 PMCID: PMC3977429 DOI: 10.1155/2014/404617
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Scheme 1Synthesis of ligand and its metal complexes.
Comparison between microwave and thermal method.
| Compound | Yield (%) | Solvent (mL) | Time | |||
|---|---|---|---|---|---|---|
| Thermal | Microwave | Thermal | Microwave | Thermal (h) | Microwave (min) | |
| [C22H18N4O4] | 82 | 95 | 100 | 2 | 7 | 3 |
| [CoLCl2] | 75 | 87 | 40 | 4 | 5 | 5 |
| [CoL(CH3COO)2] | 76 | 86 | 40 | 3 | 5 | 6 |
| [NiLCl2] | 78 | 85 | 40 | 5 | 5 | 5 |
| [NiL(CH3COO)2] | 72 | 82 | 40 | 4 | 4 | 6 |
| [CuLCl2] | 69 | 79 | 40 | 4 | 5 | 7 |
| [CuL(CH3COO)2] | 73 | 83 | 40 | 3 | 4 | 6 |
L = [(C22H18N4O4)].
Analytical data and physical properties of the ligand and complexes.
| Complexes molecular formula | Colour |
Molar conductance |
M.P. |
Mol. Wt. | Molecular weight found (calculated) % | ||||
|---|---|---|---|---|---|---|---|---|---|
| M | C | H | N | O | |||||
| [C22H18N4O4] | Colourless | 180 | 402 (401.45) | 65.66 (66.02) | 4.51 (4.75) | 13.92 (14.01) | 15.90 (15.98) | ||
| [CoL]Cl2 | Pink | 263 | 220 | 531.83 (503.78) | 11.08 (11.05) | 49.63 (49.58) | 3.38 (3.35) | 10.52 (10.49) | 12.03 (12.01) |
| [CoL(CH3COO)2] | Mauve pink | 205 | 210 | 578.93 (577.95) | 10.17 (10.14) | 45.60 (45.55) | 3.10 (3.08) | 9.67 (9.64) | 11.05 (11.02) |
| [NiL]Cl2 | Green | 220 | 215 | 531.59 (530.69) | 11.04 (11.01) | 49.66 (49.62) | 3.38 (3.36) | 10.53 (10.50) | 12.03 (12.00) |
| [NiL(CH3COO)2] | Light green | 202 | 208 | 578.69 (577.89) | 10.14 (10.10) | 45.62 (45.58) | 3.11 (3.09) | 9.67 (9.65) | 11.05 (11.02) |
| [CuL]Cl2 | Royal blue | 258 | 218 | 536.44 (535.24) | 11.84 (11.80) | 49.21 (49.18) | 3.35 (3.31) | 10.43 (10.40) | 11.93 (11.90) |
| [CuL(CH3COO)2] | Greenish blue | 198 | 212 | 583.54 (582.24) | 10.88 (10.82) | 45.24 (45.20) | 3.08 (3.05) | 9.59 (9.56) | 10.96 (10.93) |
L = [(C22H18N4O4)].
Relevant IR spectral peaks (cm−1) and their assignments.
| Complexes |
| Amide-I [ | Amide-II [ | Amide-III [ |
|
|
| |
|---|---|---|---|---|---|---|---|---|
| (asym) | (sym) | |||||||
| [C22H18N4O4] | 3483 | 1645 | 1580 | 1255 | ||||
| [CoL]Cl2 | 3250 | 1632 | 1565 | 1232 | 445 | 340 | — | |
| [CoL(CH3COO)2] | 3165 | 1640 | 1552 | 1225 | 456 | — | 1564 | 1325 |
| [NiL]Cl2 | 3153 | 1638 | 1558 | 1242 | 459 | 354 | — | |
| [NiL(CH3COO)2] | 3147 | 1625 | 1569 | 1220 | 454 | — | 1595 | 1315 |
| [CuL]Cl2 | 3150 | 1630 | 1570 | 1238 | 425 | 350 | — | |
| [CuL(CH3COO)2] | 3145 | 1628 | 1563 | 1222 | 432 | — | 1560 | 1330 |
L = [(C22H18N4O4)].
Figure 1Minimum inhibitory concentration (90%) of the synthesized ligand and its metal complexes against different clinical fluconazole-sensitive Candida isolates.
Figure 2Effect of NiCl2 complex in the concentration range of 40–80 μg/mL was studied on C. albicans STD 31. Growth curve plotted against absorbance at 595 nm and time (h) shows complete inhibition of growth at 80 μg/mL.
% Cytotoxicity by MIC of ligand and its different complexes against three fluconazole-sensitive Candida isolates.
| Complexes (µg/mL) | Control |
|
|
|
|---|---|---|---|---|
| 0 | 0 | 0 | ||
| [C22H18N4O4] | MIC | 24.7 ± 0.2 | 20.2 ± 0.8 | 18.4 ± 1.1 |
| [CoL]Cl2 | MIC | 48.5 ± 0.1 | 45.2 ± 0.2 | 41.5 ± 0.7 |
| [CoL(CH3COO)2] | MIC | 41.1 ± 0.4 | 35.0 ± 0.9 | 30.7 ± 0.3 |
| [NiL]Cl2 | MIC | 89.6 ± 0.7 | 82.1 ± 0.4 | 88.2 ± 0.6 |
| [NiL(CH3COO)2] | MIC | 71.0 ± 0.9 | 70.8 ± 0.8 | 67.1 ± 0.9 |
| [CuL]Cl2 | MIC | 63.0 ± 0.2 | 59.5 ± 0.5 | 57.2 ± 0.7 |
| [CuL(CH3COO)2] | MIC | 78.2 ± 0.6 | 74.1 ± 0.7 | 77.0 ± 0.3 |
L = [(C22H18N4O4)].